Business Description
![Talis Biomedical Corp Talis Biomedical Corp logo](https://static.gurufocus.com/logos/0C0000C1W4.png?14)
Talis Biomedical Corp
NAICS : 339112
SIC : 3845
ISIN : US87424L2079
Share Class Description:
TLIS: Ordinary SharesDescription
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.18 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | -0.35 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -12.03 | |||||
Beneish M-Score | -7.36 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.2 | |||||
3-Year EPS without NRI Growth Rate | 21.1 | |||||
3-Year FCF Growth Rate | 25.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.26 | |||||
9-Day RSI | 28.08 | |||||
14-Day RSI | 27.17 | |||||
6-1 Month Momentum % | 0.97 | |||||
12-1 Month Momentum % | 30.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.76 | |||||
Quick Ratio | 7.76 | |||||
Cash Ratio | 7.3 | |||||
Days Sales Outstanding | 175.2 | |||||
Days Payable | 50866.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | 82.19 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.33 | |||||
Operating Margin % | -18374 | |||||
Net Margin % | -17008.67 | |||||
FCF Margin % | -13411.67 | |||||
ROE % | -72.45 | |||||
ROA % | -53.13 | |||||
ROIC % | -268.84 | |||||
ROC (Joel Greenblatt) % | -397.79 | |||||
ROCE % | -63.21 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 24.48 | |||||
PB Ratio | 0.15 | |||||
Price-to-Tangible-Book | 0.15 | |||||
EV-to-EBIT | 0.61 | |||||
EV-to-EBITDA | 0.62 | |||||
EV-to-Revenue | -112.33 | |||||
EV-to-FCF | 0.84 | |||||
Price-to-Net-Current-Asset-Value | 0.18 | |||||
Price-to-Net-Cash | 0.2 | |||||
Earnings Yield (Greenblatt) % | 163.93 | |||||
FCF Yield % | -546.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Talis Biomedical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.3 | ||
EPS (TTM) ($) | -28.02 | ||
Beta | 1.77 | ||
Volatility % | 68.78 | ||
14-Day RSI | 27.17 | ||
14-Day ATR ($) | 0.531877 | ||
20-Day SMA ($) | 5.58618 | ||
12-1 Month Momentum % | 30.36 | ||
52-Week Range ($) | 3.42 - 9.6 | ||
Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Talis Biomedical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Talis Biomedical Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Talis Biomedical Corp Frequently Asked Questions
What is Talis Biomedical Corp(TLIS)'s stock price today?
The current price of TLIS is $3.89. The 52 week high of TLIS is $9.60 and 52 week low is $3.42.
When is next earnings date of Talis Biomedical Corp(TLIS)?
The next earnings date of Talis Biomedical Corp(TLIS) is 2024-11-14 Est..
Does Talis Biomedical Corp(TLIS) pay dividends? If so, how much?
Talis Biomedical Corp(TLIS) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |